Rxaminer

Acquired By DestinationRx
AI-driven platform is utilized for pharmaceutical data analysis and insights.

About Rxaminer

Rxaminer is a Healthcare company, and was acquired by DestinationRx in May 2006. AI-driven platform is utilized for pharmaceutical data analysis and insights. Its focus areas include Clinics.

Company details

Rxaminer operates as a technology company in the pharmaceutical sector, leveraging artificial intelligence to process clinical trial data and identify drug repurposing opportunities. Services include predictive analytics for research and development, enabling faster evaluation of therapeutic potentials. The platform supports global pharmaceutical entities by aggregating and interpreting vast datasets from regulatory sources. Founded details are not specified, with operations centered on digital tools rather than physical locations.

Key Metrics

Investors in Rxaminer

Rxaminer has secured backing from 1 investor. Prominent investors backing the company include ConnectureDRX.

All
InvestorDescriptionFounded YearDomainLocation
Web-based prescription drug and Medicare plan comparisons are provided.
1999drx.comLos Angeles, United States
Premium access

Investor details for Rxaminer

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Web traffic of Rxaminer

Websites that share an audience with Rxaminer (rxaminer.com).

Similar websites

Websites whose visitors overlap most with Rxaminer. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
destinationrx.com
destinationrx.com
100%
#60,249–
drx.com
78%
View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Rxaminer

Rxaminer operates as a technology company in the pharmaceutical sector, leveraging artificial intelligence to process clinical trial data and identify drug repurposing opportunities. Services include predictive analytics for research and development, enabling faster evaluation of therapeutic potentials. The platform supports global pharmaceutical entities by aggregating and interpreting vast datasets from regulatory sources. Founded details are not specified, with operations centered on digital tools rather than physical locations.

Rxaminer has 1 investor. Key investors include ConnectureDRX.

Yes. Rxaminer was acquired by DestinationRx in May 2006.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available